How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in Q2 2021?

76 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share for Q2 2021. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Q: What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690469101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 134,553,130
Total 13F shares: 33,366,478
Share change: -2,790,483
Total reported value: $130,460,427
Put/Call ratio: 18%
Price per share: $3.91
Number of holders: 76
Value change: -$11,009,099
Number of buys: 38
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 690469101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BVF INC/IL	13F	Company	4.8%	6,417,551	$25,799,000	—	31 Mar 2021	13F
EcoR1 Capital, LLC	13F	Company	4.5%	6,082,200	$24,450,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	2.8%	3,701,688	$14,882,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	2.6%	3,496,386	$14,056,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	1.9%	2,500,000	$10,050,000	—	31 Mar 2021	13F
Stonepine Capital Management, LLC	13F	Company	1.8%	2,483,059	$9,982,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.9%	1,204,365	$4,842,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.84%	1,124,872	$4,522,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.72%	962,476	$3,869,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.57%	763,837	$3,070,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	751,565	$3,021,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.44%	585,705	$2,355,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.36%	481,863	$1,938,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.34%	458,285	$1,842,000	—	31 Mar 2021	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.29%	396,870	$1,595,000	—	31 Mar 2021	13F
Tekla Capital Management LLC	13F	Company	0.28%	372,733	$1,498,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.24%	319,600	$1,285,000	—	31 Mar 2021	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.19%	251,764	$1,012,000	—	31 Mar 2021	13F
CHI Advisors LLC	13F	Company	0.18%	247,510	$995,000	—	31 Mar 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	229,400	$922,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.16%	220,357	$886,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	186,603	$750,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.13%	170,026	$683,000	—	31 Mar 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.12%	166,356	$669,000	—	31 Mar 2021	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.12%	156,482	$629,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.11%	151,030	$607,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.1%	131,834	$530,000	—	31 Mar 2021	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.09%	122,059	$491,000	—	31 Mar 2021	13F
Redmile Group, LLC	13F	Company	0.09%	121,950	$490,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	118,778	$478,000	—	31 Mar 2021	13F
DCF Advisers, LLC	13F	Company	0.08%	109,001	$438,000	—	31 Mar 2021	13F
FIRST TRUST ADVISORS LP	13F	Company	0.08%	106,796	$429,000	—	31 Mar 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.08%	104,283	$419,000	—	31 Mar 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0.07%	91,818	$369,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.06%	87,400	$351,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.06%	81,768	$329,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.06%	77,934	$314,000	—	31 Mar 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.06%	75,888	$305,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.06%	74,822	$301,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	71,956	$289,000	—	31 Mar 2021	13F
Fairpointe Capital LLC	13F	Company	0.05%	71,700	$288,000	—	31 Mar 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.05%	64,000	$257,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	56,100	$226,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	48,990	$197,000	—	31 Mar 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.04%	48,891	$197,000	—	31 Mar 2021	13F
HighVista Strategies LLC	13F	Company	0.03%	40,920	$164,000	—	31 Mar 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.03%	40,111	$161,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0.03%	40,077	$161,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	39,000	$157,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.03%	36,748	$148,000	—	31 Mar 2021	13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q2 2021

As of 30 Jun 2021, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,366,478 shares. The largest 10 holders included BVF INC/IL, EcoR1 Capital, LLC, VANGUARD GROUP INC, Artal Group S.A., Stonepine Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., Ikarian Capital, LLC, GLOBEFLEX CAPITAL L P, and MILLENNIUM MANAGEMENT LLC. This page lists 76 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-9

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.